DrugPatentWatch Database Preview

Details for Patent: 8,536,150

« Back to Dashboard

Which drugs does patent 8,536,150 protect, and when does it expire?

Patent 8,536,150 protects LEXISCAN and is included in one NDA.

This patent has four patent family members in three countries.

Summary for Patent: 8,536,150

Title:	Methods of myocardial perfusion imaging
Abstract:	The present invention provides a method of myocardial perfusion imaging using reduced doses of (1-{9-[(4S,2R,3R,5R)3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopu- rin-2-yl}pyrazol-4-yl)-N-methylcarboxamide.
Inventor(s):	Belardinelli; Luiz (Palo Alto, CA), Blackburn; Brent K. (Los Altos, CA), Gao; Zhenhai (San Jose, CA)
Assignee:	Gilead Sciences, Inc. (Foster City, CA)
Application Number:	13/525,223
Patent Claim Types: see list of patent claims	Use; Composition;

Drugs Protected by US Patent 8,536,150

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Astellas	LEXISCAN	regadenoson	SOLUTION;INTRAVENOUS	022161-001	Apr 10, 2008		RX	Yes	Yes						METHOD OF MYOCARDIAL IMAGING

Non-Orange Book US Patents Family Members for Patent 8,536,150

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
9,163,057	Methods of myocardial perfusion imaging
7,582,617	Myocardial perfusion imaging method
8,071,566	Methods of coronary imaging

International Family Members for US Patent 8,536,150

Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	3866501
Canada	2439222
Canada	2671940
World Intellectual Property Organization (WIPO)	0162979